Stock Rating Downgrade
The Value Trend Rating for Lipocine Inc (NASDAQ: LPCN) weakened recently from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Lipocine Inc (NASDAQ: LPCN) stock declined modestly by -1.2% on 10/11/24. The stock closed at $5.14. However, this decline was accompanied by below average trading volume at 78% of normal. The stock has risen 14.7% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
LPCN’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Lipocine has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Lipocine has a neutral Appreciation Score of 52 but a good Power Rating of 70, resulting in the High Neutral Value Trend Rating.
Be the first to comment